Jatinder Dhaliwal - Jul 5, 2024 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Vinay Shah, Attorney-in-fact for Jatinder Dhaliwal
Stock symbol
VRPX
Transactions as of
Jul 5, 2024
Transactions value $
$0
Form type
4
Date filed
7/9/2024, 04:02 PM
Previous filing
Apr 11, 2024
Next filing
Oct 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +2.5K $0.00 2.5K Jul 5, 2024 Common Stock 2.5K $0.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the twelve-month anniversary of the grant date.